Stoke Therapeutics (STOK) Profit After Tax: 2022-2025
Historic Profit After Tax for Stoke Therapeutics (STOK) over the last 4 years, with Sep 2025 value amounting to -$38.3 million.
- Stoke Therapeutics' Profit After Tax fell 45.09% to -$38.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $40.6 million, marking a year-over-year increase of 138.47%. This contributed to the annual value of -$89.0 million for FY2024, which is 15.01% up from last year.
- As of Q3 2025, Stoke Therapeutics' Profit After Tax stood at -$38.3 million, which was down 63.30% from -$23.5 million recorded in Q2 2025.
- Stoke Therapeutics' Profit After Tax's 5-year high stood at $112.9 million during Q1 2025, with a 5-year trough of -$38.3 million in Q3 2025.
- In the last 3 years, Stoke Therapeutics' Profit After Tax had a median value of -$25.7 million in 2024 and averaged -$13.0 million.
- Over the last 5 years, Stoke Therapeutics' Profit After Tax had its largest YoY gain of 527.99% in 2025, and its largest YoY loss of 45.09% in 2025.
- Quarterly analysis of 4 years shows Stoke Therapeutics' Profit After Tax stood at -$25.7 million in 2022, then dropped by 5.08% to -$27.0 million in 2023, then skyrocketed by 61.12% to -$10.5 million in 2024, then plummeted by 45.09% to -$38.3 million in 2025.
- Its Profit After Tax was -$38.3 million in Q3 2025, compared to -$23.5 million in Q2 2025 and $112.9 million in Q1 2025.